CHOP (C/EBP homologous protein) and ASNS (asparagine synthetase) induction in cybrid cells harboring MELAS and NARP mitochondrial DNA mutations

Mitochondrion

Volumn 7, Issue 1-2, 2007, Pages 80-88

  Fujita, Yasunori ^a,b   Ito, Masafumi ^a   Nozawa, Yoshinori ^a   Yoneda, Makoto ^c   Oshida, Yoshiharu ^d   Tanaka, Masashi ^e  

^a GIFU INTERNATIONAL INSTITUTE OF BIOTECHNOLOGY   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF FUKUI   (Japan)

^d NAGOYA UNIVERSITY   (Japan)

^e TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

ASNS; CHOP; DNA microarray; MELAS; Mitochondrial dysfunction; NARP

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; ADENOSINE TRIPHOSPHATASE; ARGININE; ASPARTATE AMMONIA LIGASE; CCAAT ENHANCER BINDING PROTEIN; CYTOSINE; MESSENGER RNA; MITOCHONDRIAL DNA; THYMINE; TRANSFER RNA;

ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; DNA MICROARRAY; ENHANCER REGION; GENE EXPRESSION; GENE IDENTIFICATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC CODE; HUMAN; HUMAN CELL; HYBRID CELL; MELAS SYNDROME; MICROARRAY ANALYSIS; MUTATIONAL ANALYSIS; NARP SYNDROME; NUCLEOTIDE SEQUENCE; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN BINDING; RNA INTERFERENCE; UPREGULATION;

ACTIVATING TRANSCRIPTION FACTOR 4; ANTIOXIDANTS; ASPARTATE-AMMONIA LIGASE; ATAXIA; DNA, MITOCHONDRIAL; HUMANS; HYBRID CELLS; MELAS SYNDROME; MITOCHONDRIAL DISEASES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOSARCOMA; PERIPHERAL NERVOUS SYSTEM DISEASES; RETINITIS PIGMENTOSA; RNA INTERFERENCE; ROTENONE; SYNDROME; TRANSCRIPTION FACTOR CHOP; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 33847653346     PISSN: 15677249     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mito.2006.11.003     Document Type: Article

References (45)

1. Averous J., Bruhat A., Jousse C., Carraro V., Thiel G., and Fafournoux P. Induction of CHOP expression by amino acid limitation requires both ATF4 expression and ATF2 phosphorylation. J. Biol. Chem. 279 (2004) 5288-5297
2. Bruhat A., Jousse C., Carraro V., Reimold A.M., Ferrara M., and Fafournoux P. Amino acids control mammalian gene transcription: activating transcription factor 2 is essential for the amino acid responsiveness of the CHOP promoter. Mol. Cell. Biol. 20 (2000) 7192-7204
3. Bruhat A., Averous J., Carraro V., Zhong C., Reimold A.M., Kilberg M.S., and Fafournoux P. Differences in the molecular mechanisms involved in the transcriptional activation of the CHOP and asparagine synthetase genes in response to amino acid deprivation or activation of the unfolded protein response. J. Biol. Chem. 277 (2002) 48107-48114
4. Carriere A., Carmona M.C., Fernandez Y., Rigoulet M., Wenger R.H., Penicaud L., and Casteilla L. Mitochondrial reactive oxygen species control the transcription factor CHOP-10/GADD153 and adipocyte differentiation: a mechanism for hypoxia-dependent effect. J. Biol. Chem. 279 (2004) 40462-40469
5. Chen C., and Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7 (1987) 2745-2752
6. Chomyn A., Martinuzzi A., Yoneda M., Daga A., Hurko O., Johns D., Lai S.T., Nonaka I., Angelini C., and Attardi G. MELAS mutation in mtDNA binding site for transcription termination factor causes defects in protein synthesis and in respiration but no change in levels of upstream and downstream mature transcripts. Proc. Natl. Acad. Sci. USA 89 (1992) 4221-4225
7. Crimi M., Bordoni A., Menozzi G., Riva L., Fortunato F., Galbiati S., Del Bo R., Pozzoli U., Bresolin N., and Comi G.P. Skeletal muscle gene expression profiling in mitochondrial disorders. FASEB J. 19 (2005) 866-868
8. Fafournoux P., Bruhat A., and Jousse C. Amino acid regulation of gene expression. Biochem. J. 351 (2000) 1-12
9. Garcia J.J., Ogilvie I., Robinson B.H., and Capaldi R.A. Structure, functioning, and assembly of the ATP synthase in cells from patients with the T8993G mitochondrial DNA mutation. Comparison with the enzyme in Rho(0) cells completely lacking mtDNA. J. Biol. Chem. 275 (2000) 11075-11081
10. Goto Y., Nonaka I., and Horai S. A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 348 (1990) 651-653
11. Guyton K.Z., Xu Q., and Holbrook N.J. Induction of the mammalian stress response gene GADD153 by oxidative stress: role of AP-1 element. Biochem. J. 314 Pt 2 (1996) 547-554
12. Harding H.P., Novoa I., Zhang Y., Zeng H., Wek R., Schapira M., and Ron D. Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol. Cell 6 (2000) 1099-1108
13. Holt I.J., Harding A.E., Petty R.K., and Morgan-Hughes J.A. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am. J. Hum. Genet. 46 (1990) 428-433
14. Ichiki T., Tanaka M., Kobayashi M., Sugiyama N., Suzuki H., Nishikimi M., Ohnishi T., Nonaka I., Wada Y., and Ozawa T. Disproportionate deficiency of iron-sulfur clusters and subunits of complex I in mitochondrial encephalomyopathy. Pediatr. Res. 25 (1989) 194-201
15. Ino H., Tanaka M., Ohno K., Hattori K., Ikebe S., Sano T., Ozawa T., Ichiki T., Kobayashi M., and Wada Y. Mitochondrial leucine tRNA mutation in a mitochondrial encephalomyopathy. Lancet 337 (1991) 234-235
16. James A.M., Wei Y.H., Pang C.Y., and Murphy M.P. Altered mitochondrial function in fibroblasts containing MELAS or MERRF mitochondrial DNA mutations. Biochem. J. 318 Pt 2 (1996) 401-407
17. Jiang H.Y., and Wek R.C. Phosphorylation of the alpha-subunit of the eukaryotic initiation factor-2 (eIF2alpha) reduces protein synthesis and enhances apoptosis in response to proteasome inhibition. J. Biol. Chem. 280 (2005) 14189-14202
18. Jousse C., Averous J., Bruhat A., Carraro V., Mordier S., and Fafournoux P. Amino acids as regulators of gene expression: molecular mechanisms. Biochem. Biophys. Res. Commun. 313 (2004) 447-452
19. Kirino Y., Yasukawa T., Ohta S., Akira S., Ishihara K., Watanabe K., and Suzuki T. Codon-specific translational defect caused by a wobble modification deficiency in mutant tRNA from a human mitochondrial disease. Proc. Natl. Acad. Sci. USA 101 (2004) 15070-15075
20. Koga Y., Akita Y., Nishioka J., Yatsuga S., Povalko N., Tanabe Y., Fujimoto S., and Matsuishi T. L-arginine improves the symptoms of strokelike episodes in MELAS. Neurology 64 (2005) 710-712
21. Li N., Ragheb K., Lawler G., Sturgis J., Rajwa B., Melendez J.A., and Robinson J.P. Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. J. Biol. Chem. 278 (2003) 8516-8525
22. Lu P.D., Harding H.P., and Ron D. Translation reinitiation at alternative open reading frames regulates gene expression in an integrated stress response. J. Cell. Biol. 167 (2004) 27-33
23. Moudy A.M., Handran S.D., Goldberg M.P., Ruffin N., Karl I., Kranz-Eble P., DeVivo D.C., and Rothman S.M. Abnormal calcium homeostasis and mitochondrial polarization in a human encephalomyopathy. Proc. Natl. Acad. Sci. USA 92 (1995) 729-733
24. Nijtmans L.G., Henderson N.S., Attardi G., and Holt I.J. Impaired ATP synthase assembly associated with a mutation in the human ATP synthase subunit 6 gene. J. Biol. Chem. 276 (2001) 6755-6762
25. Pavlakis S.G., Phillips P.C., DiMauro S., De Vivo D.C., and Rowland L.P. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann. Neurol. 16 (1984) 481-488
26. Peng T., Golub T.R., and Sabatini D.M. The immunosuppressant rapamycin mimics a starvation-like signal distinct from amino acid and glucose deprivation. Mol. Cell. Biol. 22 (2002) 5575-5584
27. Ron D. Translational control in the endoplasmic reticulum stress response. J. Clin. Invest. 110 (2002) 1383-1388
28. Rusanen H., Majamaa K., and Hassinen I.E. Increased activities of antioxidant enzymes and decreased ATP concentration in cultured myoblasts with the 3243A->G mutation in mitochondrial DNA. Biochim. Biophys. Acta 1500 (2000) 10-16
29. Rutkowski D.T., and Kaufman R.J. A trip to the ER: coping with stress. Trends. Cell Biol. 14 (2004) 20-28
30. Sandhu J.K., Sodja C., McRae K., Li Y., Rippstein P., Wei Y.H., Lach B., Lee F., Bucurescu S., Harper M.E., and Sikorska M. Effects of nitric oxide donors on cybrids harbouring the mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) A3243G mitochondrial DNA mutation. Biochem. J. 391 (2005) 191-202
31. Shoffner J.M., Fernhoff P.M., Krawiecki N.S., Caplan D.B., Holt P.J., Koontz D.A., Takei Y., Newman N.J., Ortiz R.G., Polak M., et al. Subacute necrotizing encephalopathy: oxidative phosphorylation defects and the ATPase 6 point mutation. Neurology 42 (1992) 2168-2174
32. Siu F., Chen C., Zhong C., and Kilberg M.S. CCAAT/enhancer-binding protein-beta is a mediator of the nutrient-sensing response pathway that activates the human asparagine synthetase gene. J. Biol. Chem. 276 (2001) 48100-48107
33. Siu F., Bain P.J., LeBlanc-Chaffin R., Chen H., and Kilberg M.S. ATF4 is a mediator of the nutrient-sensing response pathway that activates the human asparagine synthetase gene. J. Biol. Chem. 277 (2002) 24120-24127
34. Sood R., Porter A.C., Olsen D.A., Cavener D.R., and Wek R.C. A mammalian homologue of GCN2 protein kinase important for translational control by phosphorylation of eukaryotic initiation factor-2alpha. Genetics 154 (2000) 787-801
35. Tanaka M., Miyabayashi S., Nishikimi M., Suzuki H., Shimomura Y., Ito K., Narisawa K., Tada K., and Ozawa T. Extensive defects of mitochondrial electron-transfer chain in muscular cytochrome c oxidase deficiency. Pediatr. Res. 24 (1988) 447-454
36. Tanaka M., Ino H., Ohno K., Ohbayashi T., Ikebe S., Sano T., Ichiki T., Kobayashi M., Wada Y., and Ozawa T. Mitochondrial DNA mutations in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). Biochem. Biophys. Res. Commun. 174 (1991) 861-868
37. Tanaka M., Borgeld H.J., Zhang J., Muramatsu S., Gong J.S., Yoneda M., Maruyama W., Naoi M., Ibi T., Sahashi K., Shamoto M., Fuku N., Kurata M., Yamada Y., Nishizawa K., Akao Y., Ohishi N., Miyabayashi S., Umemoto H., Muramatsu T., Furukawa K., Kikuchi A., Nakano I., Ozawa K., and Yagi K. Gene therapy for mitochondrial disease by delivering restriction endonuclease SmaI into mitochondria. J. Biomed. Sci. 9 (2002) 534-541
38. Tatuch Y., Christodoulou J., Feigenbaum A., Clarke J.T., Wherret J., Smith C., Rudd N., Petrova-Benedict R., and Robinson B.H. Heteroplasmic mtDNA mutation (T--G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high. Am. J. Hum. Genet. 50 (1992) 852-858
39. Turrens J.F., and Boveris A. Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem. J. 191 (1980) 421-427
40. Yasukawa T., Suzuki T., Ueda T., Ohta S., and Watanabe K. Modification defect at anticodon wobble nucleotide of mitochondrial tRNAs(Leu)(UUR) with pathogenic mutations of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. J. Biol. Chem. 275 (2000) 4251-4257
41. Yoneda M., Tanaka M., Nishikimi M., Suzuki H., Tanaka K., Nishizawa M., Atsumi T., Ohama E., Horai S., Ikuta F., et al. Pleiotropic molecular defects in energy-transducing complexes in mitochondrial encephalomyopathy (MELAS). J. Neurol. Sci. 92 (1989) 143-158
42. Yoneda M., Miyatake T., and Attardi G. Complementation of mutant and wild-type human mitochondrial DNAs coexisting since the mutation event and lack of complementation of DNAs introduced separately into a cell within distinct organelles. Mol. Cell. Biol. 14 (1994) 2699-2712
43. Yoshida H., Okada T., Haze K., Yanagi H., Yura T., Negishi M., and Mori K. ATF6 activated by proteolysis binds in the presence of NF-Y (CBF) directly to the cis-acting element responsible for the mammalian unfolded protein response. Mol. Cell. Biol. 20 (2000) 6755-6767
44. Zhang J., Yoneda M., Naruse K., Borgeld H.J., Gong J.S., Obata S., Tanaka M., and Yagi K. Peroxide production and apoptosis in cultured cells carrying mtDNA mutation causing encephalomyopathy. Biochem. Mol. Biol. Int. 46 (1998) 71-79
45. Zhang P., McGrath B.C., Reinert J., Olsen D.S., Lei L., Gill S., Wek S.A., Vattem K.M., Wek R.C., Kimball S.R., Jefferson L.S., and Cavener D.R. The GCN2 eIF2alpha kinase is required for adaptation to amino acid deprivation in mice. Mol. Cell. Biol. 22 (2002) 6681-6688